The landscape of dementia diagnosis has progressed substantially with the arrival of innovative biomarkers, which include amyloid PET scans, tau imaging, and blood-dependent exams that may detect Alzheimer's pathology many years before indications arise. Even though these technological developments represent extraordinary development in knowing neurodegenerative diseases, they may hav... https://johnt763tdl2.mywikiparty.com/user